|
Opening Plenary: Types of Evidence
Chair: Steven K. Clinton, MD, PhD, The Ohio State University
Chair: Susan T. Mayne, PhD, Yale University and Yale Cancer Center
Introduction: Steven Clinton, MD, PhD, and Susan Mayne, PhD
|
Presentation titles with this icon have related pdf files for download.
|
Diet and cancer: the role of observational studies
Ed Giovannucci, MD, ScD, Harvard School of Public Health |
Diet and cancer: the role of clinical trials JoAnn Manson, MD, DrPH, Harvard Medical School |
Diet and cancer prevention: lessons from animal models and transdisciplinary studies
Stephen Hursting, PhD, MPH, University of Texas at Austin |
|
Split Session A: Emerging Topics in Diet and Cancer Research
Chair: Robert S. Chapkin, PhD, Texas A&M University
Chair: Stephen D. Hursting, PhD, MPH, University of Texas at Austin
|
Molecular mechanisms and chemoprotective properties of n-3 fatty acids: new insights
Robert Chapkin, PhD, Texas A&M |
Clinical and translational studies of the anti-colorectal cancer activity of the n-3 polyunsaturated fatty acid eicosapentaenoic acid
Mark Hull, PhD, FRCP, University of Leeds |
New insights into mechanisms of calorie restriction mediated inhibition of carcinogenesis: identifying targets for cancer prevention
John DiGiovanni, PhD, University of Texas at Austin |
New technologies and analytic techniques for dietary assessment
Amy Subar, PhD, MPH, RD, National Cancer Institute |
|
Split Session B: Cancer Treatment and Survivorship
Chair: Cheryl L. Rock, PhD, RD, University of California, San Diego
Chair: John A. Milner, PhD, National Cancer Institute
|
The impact of nutrition intervention in cancer cachexia
Carla Prado, PhD, National Institutes of Health |
Micronutrient status and the nervous system in cancer: a balance between feeding the host and starving the tumor
Ralph Green, MD, PhD, FRCPath, University of California, Davis |
Soy intake for the breast cancer survivor: evidence from the epidemiological literature
Bette Caan, DrPH, Kaiser Permanente Division of Research |
Biological factors involved in mediating the effects of soy foods on breast cancer survivors
Leena Hilakivi-Clarke, PhD, Georgetown University |
|
Friday, November 4
|
|
Breakfast Session
The WCRF/AICR Continuous Update Project: Keeping the evidence on food, nutrition, physical activity, and cancer up to date
Background and Methods
Martin Wiseman, FRCP, FRCPath, World Cancer Research Fund International
Results So Far
Rachel Thompson, PhD
|
|
Split Session C: Cancer Stem Cells
Chair: Young S. Kim, PhD, National Cancer Institute
Chair: John A. Milner, PhD, National Cancer Institute
|
Normal stem cells vs. cancer stem cells: an overview
Max Wicha, MD, University of Michigan |
Control of stem cells by diet and systemic factors in the Drosophila ovary
Daniela Drummond-Barbosa, PhD, Johns Hopkins University |
The prostate stem cell as a target for prevention and treatment: vitamin D induced differentiation
Scott Cramer, PhD, University of Colorado, Denver |
Dietary agents and stem cell survival proteins in skin cancer
Richard Eckert, PhD, University of Maryland |
Targeting intestinal stem cells with dietary components
Shrikant Anant, PhD, The University of Kansas |
|
Split Session D: Sedentary Behavior and Physical Activity
Chair: Christine Friedenreich, PhD, Alberta Health Services-Cancer Care
Chair: June Stevens, MS, PhD, University of North Carolina at Chapel Hill
|
Observational and experimental evidence for the role of physical activity in cancer risk
Christine Friedenreich, PhD, Alberta Health Services-Cancer Care |
Exercise rehabilitation following a cancer diagnosis: cardiorespiratory fitness to prognosis outcomes
Lee W. Jones, PhD, Duke University |
Sedentary behavior: definitions and distinctions for cancer-prevention research
Neville Owen, PhD, Baker IDI Heart and Diabetes Institute |
Sedentary behaviors and cancer: possible risks and biological mechanisms
Charles E. Matthews, PhD, National Cancer Institute |
|
Closing Plenary: Vitamin D and Cancer
Chair: Steven K. Clinton, MD, PhD, The Ohio State University
Chair: Susan T. Mayne, PhD, Yale University and Yale Cancer Center
|
Vitamin D and cancer – an overview
Susan Mayne, PhD, Yale University |
Vitamin D and cancer – how strong is the evidence from observational studies?
Demetrius Albanes, MD, National Cancer Institute |
Cellular and molecular actions of vitamin D in cancer
Glenville Jones, PhD, Queen's University |
Using animal models to extend our understanding of the role vitamin D plays in cancer prevention
James Fleet, PhD, Purdue University |
Vitamin D and cancer – summary and panel discussion
Steven Clinton, MD, PhD, The Ohio State University |